Drug Target Identified for Common Childhood Blood Cancer
NYU Langone researchers describe advanced genetic scanning techniques to identify a possible new drug target for acute lymphoblastic leukemia.
Drug Targets Folate Receptor in Ovarian Cancer
A clinical trial at NYU Langone’s Perlmutter Cancer Center is testing a highly selective drug for people with platinum-sensitive ovarian cancer.
dual-use-research-of-concern-flowchart.pdf
E-Cigarette Smoke Causes Lung Cancer in Mice
NYU Langone researchers found that exposure to e-cigarette vaping smoke caused mice to develop lung cancer.
E-Cigarettes May Lead to Increased Tobacco Use
NYU Langone researchers find use of e-cigarettes and other alternative tobacco products may lead to increased tobacco use later in life.
E-Cigarettes Possibly Linked to Erectile Dysfunction
New research from NYU Langone finds link between men with no history of heart disease who use e-cigarettes daily and erectile dysfunction.
Early Antibiotic Overexposure Linked to Metabolic Disorders
NYU Langone study shows the dangers of repeated antibiotic use extend beyond the immediate side effects.
Early Detection & Intervention Help Keep Woman Melanoma-Free
When 27-year-old Alexa Oberle’s annual skin check revealed a precancerous spot, she was quickly treated by top Long Island skin cancer experts at NYU Langone.
Early Detection Can Improve Survival for Pancreatic Cancer
Dr. Diane Simeone, Pancreatic Cancer Center director at NYU Langone’s Perlmutter Cancer Center, discusses how early detection can save lives.
Early Detection Can Stop Pancreatic Cancer Before It Starts
Researchers at the Pancreatic Cancer Early Detection and Prevention Center at Perlmutter Cancer Center promote screening for those at high-risk.